Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities

Chapter: 4 GLOBAL PEDIATRICS MEDICINE MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SHORT TERM ILLNESS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Ear Infection

 4.2.4.1. Market size and forecast

4.2.5. Upper Respiratory Infections

 4.2.5.1. Market size and forecast

4.2.6. Others

 4.2.6.1. Market size and forecast

4.3. CHRONIC ILLNESS 

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.2.4. Cystic Fibrosis

 4.3.4.1. Market size and forecast

4.3.5. Diabetes

 4.3.5.1. Market size and forecast

4.3.6. Others

 4.3.6.1. Market size and forecast

Chapter: 5 GLOBAL PEDIATRICS MEDICINE MARKET, BY REGION

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.2.4. North America Pediatric Medicine Market by Type

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast

5.3.4. Europe Pediatrics Medicine Market by Type

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.3. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast
5.4.3.3. China market size and forecast
5.4.3.3. Australia market size and forecast
5.4.3.4. India market size and forecast
5.4.3.7. Rest of Asia-Pacific market size and forecast

5.4.4. Asia-Pacific Pediatric Medicine Market by Type

5.5. LAMEA

5.5.1. Key market trends
5.5.3. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Brazil market size and forecast
5.5.3.3. Turkey market size and forecast
5.5.3.3. Argentina market size and forecast
5.5.3.4. South Africa market size and forecast
5.5.3.5. Rest of LAMEA market size and forecast

5.5.4. LAMEA Pediatric Medicine Market by Type

Chapter: 6 COMPANY PROFILES

6.1. LUPIN

6.1.1. Operating business segments
6.1.3. Business performance
6.1.3. Key strategic moves and developments

6.3. GLAXOSMITHKLINE PLC

6.3.1. Operating business segments
6.3.3. Business performance
6.3.3. Key strategic moves and developments

6.3. PFIZER INC.

6.3.1. Operating business segments
6.3.3. Business performance
6.3.3. Key strategic moves and developments

6.4. SANOFI S.A.

6.4.1. Operating business segments
6.4.3. Business performance
6.4.3. Key strategic moves and developments

6.5. F.HOFFMAN-LA ROCHE LTD.

6.5.1. Operating business segments
6.5.3. Business performance
6.5.3. Key strategic moves and developments

6.6. ABBOTT LABORATORIES

6.6.1. Operating business segments
6.6.3. Business performance
6.6.3. Key strategic moves and developments

6.7. HERON THERAPEUTICS, INC.

6.7.1. Operating business segments
6.7.3. Business performance
6.7.3. Key strategic moves and developments

6.8. ELI LILLY AND COMPANY

6.8.1. Operating business segments
6.8.3. Business performance
6.8.3. Key strategic moves and developments

6.9. NOVARTIS A.G

6.9.1. Operating business segments
6.9.3. Business performance
6.9.3. Key strategic moves and developments

6.10. CIPLA INC.

6.10.1. Operating business segments
6.10.3. Business performance
6.10.3. Key strategic moves and developments